Delivery Order SPE2DR25D7056-SPE2DR26FV8WS
Award Date 1/28/26
Potential Completion Date 2/19/26
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $9,606.42 by the Defense Logistics Agency on January 12, 2026, for the supply of Ryanodex 250 mg vials. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order is executed under...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $16,010.70 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Ryanodex 250 mg vials. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,601.07 for Ryanodex 250 mg vials. The delivery order, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, represents a firm fixed-price transaction with no set-aside designation. This award is a child contract issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $1,605.44 and an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,010.70 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Ryanodex 250 mg vials. This non-competitive delivery order, which is a child contract under a larger vehicle, is scheduled for completion by February 10, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $9,632.64 delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials under a firm fixed price contract. The award was announced on September 2, 2025, with an ultimate completion date of September 23, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,803.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Ryanodex 250 mg vials. The order is scheduled for completion by February 11, 2026, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation and was competitively awarded through an open procurement process. This award is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,816.32 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting...
- The Defense Logistics Agency awarded a $1,601.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials, with an ultimate completion date of January 5, 2026. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials under a firm fixed price contract. The delivery order, valued at $9,632.64, was competitively awarded without set-aside designation and carries an ultimate completion date of September 2, 2025. Performance of this contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and operates as a major pharmaceutical...